Quick To Market™ is a unique Patheon-only program that offers accelerated transfer of commercially available products from an existing manufacturing plant to a plant within Patheon’s network. The program was formally established as a service within Patheon after excellent results and significant client satisfaction with recent rapid product transfers.

The Quick to Market™ program supplements Patheon’s already established Quick to Clinic™ program, which accelerates the development of early stage molecules at pre-clinical status and allows rapid distribution of drug product to phase 1 clinical trials.